AVITA Medical, a global regenerative medicine company, announced that the U.S. Food and Drug Administration (FDA) approved the Company’s Premarket Approval (PMA) application to market the RECELL® Autologous Cell Harvesting Device

This content is restricted to site members. If you are an existing user, please log in. New users may register below.

Existing Users Log In